Artax Biopharma, Inc. research brief
CIK 1587661
Generated Nov. 19, 2026, 1 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: CAMBRIDGE Massachusetts. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.
- May 5, 2026 · D/A · 0001587661-26-000002 · Source evidence
Reported offering amount: 19000000 USD. Reported amount sold: 19000000 USD.
- July 29, 2025 · D/A · 0001587661-25-000003 · Source evidence
Reported offering amount: 11000000 USD. Reported amount sold: 11000000 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “Artax Biopharma, Inc. research brief,” CIK 1587661, retrieved Nov. 19, 2026, 1 p.m.. Cite the specific accessions used. No amounts have been summed.